Cellular insulin resistance in polycystic ovary syndrome (PCOS) has been shown to involve a novel postbinding defect in insulin signal transduction. To find possible mechanisms for this defect, adipocytes were isolated from age-and weight-matched obese normal cycling (NC) and PCOS subjects. Insulin sensitivity for glucose transport stimulation was impaired in PCOS adipocytes (EC 50 ϭ 290 Ϯ 42 pmol/L) compared to that in NC cells (93 Ϯ 14; P Ͻ 0.005). The lipolytic responses to isoproterenol as well as maximal suppression by insulin were similar in NC and PCOS adipocytes. However, PCOS cells were less sensitive to the antilipolytic effect of insulin (EC 50 ϭ 115 Ϯ 33 pmol/L) compared to NC cells (42 Ϯ 8; P Ͻ 0.01). Treatment of adipocytes from NC subjects with the adenosine receptor agonist N 6 -phenylisopropyl adenosine had no effect on either insulin responsiveness or sensitivity for glucose transport stimulation. However, N 6 -phenylisopropyl adenosine treatment was able to normalize insulin sensitivity in PCOS cells (EC 50 ϭ 285 Ϯ 47 vs. 70 Ϯ 15 pmol/L, before and after treatment; P Ͻ 0.05). In conclusion, our results suggest that insulin resistance in PCOS, as accessed in the adipocyte, occurs at an early step in insulin signaling that is common for glucose transport and lipolysis. In addition, this insulin resistance involves an impairment of the system by which adenosine acts to modulate insulin signal
phenylisopropyl adenosine treatment was able to normalize insulin sensitivity in PCOS cells (EC 50 ϭ 285 Ϯ 47 vs. 70 Ϯ 15 pmol/L, before and after treatment; P Ͻ 0.05). In conclusion, our results suggest that insulin resistance in PCOS, as accessed in the adipocyte, occurs at an early step in insulin signaling that is common for glucose transport and lipolysis. In addition, this insulin resistance involves an impairment of the system by which adenosine acts to modulate insulin signal transduction. (J Clin Endocrinol Metab 82: 1421-1425, 1997) P OLYCYSTIC ovary syndrome (PCOS), a complex neuroendocrine-metabolic disorder, is associated with insulin resistance and a high prevalence of obesity (1, 2) . Insulin resistance in PCOS appears to be independent of, but is amplified by, obesity (3) (4) (5) (6) (7) . Recently, several laboratories have investigated the cellular mechanism(s) underlying insulin resistance in PCOS employing a classical insulin target tissue, isolated adipocytes. The most striking common finding in these studies was a large reduction in insulin sensitivity for glucose transport stimulation in the face of normal insulin binding (8 -10) . Thus, insulin resistance in PCOS represents postbinding defects in signal transduction.
In the current report, efforts have been made to further characterize the insulin resistance in adipocytes from obese PCOS and weight-matched normal cycling (NC) women. This study was instigated by the observation that experimentally induced depletion of cellular adenosine in rat adipocytes resulted in an impaired insulin sensitivity of glucose transport stimulation with normal binding (11, 12) , a condition that resembles the behavior of adipocytes in PCOS.
Subjects and Methods

PCOS subjects
Eleven women between the ages of 21-36 yr were studied. All were characterized by ammenorhea or persistent oligomenorrhea of perimenarchial onset, clinical or biochemical evidence of hyperandrogenism, and polycystic ovaries documented by ultrasonography. On the basis of clinical examination, there was no evidence of acanthosis nigricans. Clinical characteristics are presented in Table 1 .
Normal subjects
Seven NC women matched for age (range, 28 -33 yr) and weight (Table 1) served as controls. They were in general good health, with no clinical evidence of hyperandrogenism. All had 27-to 32-day cycles and were studied during the early follicular phase (days 2-5) of the menstrual cycle. Neither PCO nor NC subjects had used any hormonal preparation during the 3 months preceding the study. 
Preparation of human adipocytes
Adipose tissue was obtained by open biopsy of the lower abdominal wall using a previously described method (15) . Isolated adipocytes were prepared by a modification (15) of the method of Rodbell (16) . After digestion and filtration, the cells were washed four times in a buffer consisting of 150 mmol/L NaCl, 5 mmol/L KCl, 1.2 mmol/L MgSO 4 , 1.2 mmol/L CaCl 2 , 2.5 mmol/L NaH 2 PO 4 , 10 mmol/L HEPES, and 2 mmol/L pyruvate, pH 7.4, supplemented with 4% BSA. Cells were then resuspended at approximately 5 ϫ 10 5 cells/mL. Due to the limited amount of tissue available from each biopsy, not all of the studies described below were performed on each subject. The number of subjects assayed is given with each set of results.
Cell counts were performed by a modification of method III of Hirsch and Gallian (17) , in which cells were fixed in 2% osmium tetroxide and counted with a model ZB Coulter counter (Coulter Electronics, Hialeah, FL) using a 400-m aperture tube.
Insulin binding to adipocytes
Isolated cells (ϳ2 ϫ 10 5 cells/mL) were combined with [ 125 I]insulin (33 pmol/L) and varying concentrations of unlabeled insulin (0 -18 nmol/L). Binding was measured after incubation for 1 h at 37 C using a previously described method (18) .
3-OMG transport
Adipocytes (ϳ5 ϫ 10 5 cells/mL) were incubated at 37 C in the absence or presence of varying concentrations of insulin (60 min). Transport activity was assessed by measuring initial rates of uptake of tracer amounts (15-20 mol/L) of 3-OMG, using a modification (15) of the method of Whitesell and Gliemann (19) .
Antilipolysis
The antilipolytic effect of insulin was measured as the inhibition of glycerol release into the buffer. Cells (ϳ4 ϫ 10 5 cells/mL) were first treated for 30 min with or without isoproterenol (1 mol/L). Varying concentrations of insulin were then added. After an additional 60-min incubation, buffer was collected, and glycerol content was determined by a colorimetric method (20) . All values were corrected for background release measured on cells processed without any incubation period.
Data analysis
Results are expressed as the mean Ϯ sem and were compared by Student's t test for paired or unpaired data, when appropriate, employing the Statview SE ϩ graphics program. Significance was accepted at P Ͻ 0.05 (two-tailed t test). EC 50 values for antilipolysis and glucose transport stimulation were obtained by log-logit transformations of individual data.
Results
Subjects
The clinical and laboratory characteristics of the study subjects are summarized in Table 1 . The groups were matched for age and body mass index (range, 29 -49 for NC and 28 -51 for PCOS). Adipose tissue distribution, as indicated by the waist/hip ratio, did not differ between groups (0.82 Ϯ 0.02 vs. 0.86 Ϯ 0.02 for NC vs. PCOS). Adipocyte cell volume, another measure of obesity, also did not differ between groups (990 Ϯ 127 vs. 1197 Ϯ 99 pL for NC vs. PCOS). Testosterone and LH levels as well as the LH/FSH ratio were all elevated in the PCOS group. Fasting glucose levels did not differ between groups, ruling out overt diabetes, but the PCOS subjects were hyperinsulinemic, suggesting insulin resistance. This was confirmed by the response to an iv glucose tolerance test, showing a 50% lower (P Ͻ 0.05) insulin sensitivity index in PCOS (Table 1) .
Insulin binding and glucose transport activity
Insulin binding to adipocytes was measured at 37 C under the same conditions as insulin stimulation of glucose transport. Specific binding of a tracer (33 pmol/L) concentration of insulin was not significantly different between the NC (0.73 Ϯ 0.11%/10 5 cells; n ϭ 7) and PCOS (0.98 Ϯ 0.14; n ϭ 11) groups. Insulin receptor affinity, measured by displacement of labeled insulin, was also the same in cells from both groups (not shown).
Absolute 3-OMG transport activities in the basal state were comparable in cells from both groups (0.35 Ϯ 0.08 vs. 0.27 Ϯ 0.05 pmol/10 5 cells⅐10 s in NC and PCOS, respectively). Maximally insulin-stimulated 3-OMG transport rates also did not differ (1.17 Ϯ 0.23 vs. 0.99 Ϯ 0.23). However, PCOS cells had greatly impaired insulin sensitivity (EC 50 ϭ 290 Ϯ 42 pmol/L; n ϭ 11) compared to controls (93 Ϯ 14; n ϭ 7; P Ͻ 0.005).
Lipolysis
To determine whether responses other than glucose transport were subject to impaired insulin signal transduction, the antilipolytic effect of insulin was studied in adipocytes from NC and PCOS subjects. Basal lipolysis was similar in both groups (0.12 Ϯ 0.03 vs. 0.11 Ϯ 0.02 mol glycerol/10 5 cells in NC and PCOS). Isoproterenol stimulated lipolysis to the same level in NC (0.27 Ϯ 0.05) and PCOS (0.24 Ϯ 0.03) cells. Insulin maximally inhibited stimulated lipolysis in NC cells by 40 Ϯ 8%. The maximal antilipolytic effect of insulin in PCOS cells (33 Ϯ 6% inhibition) did not differ significantly from the control value. However, insulin sensitivity for the antilipolytic effect in PCOS subjects (EC 50 ϭ 115 Ϯ 33 pmol/L; n ϭ 8) was significantly impaired compared to that in NC cells (42 Ϯ 8; n ϭ 6; P Ͻ 0.01).
Adenosine regulation of insulin sensitivity
The characteristics of insulin resistance in adipocytes from PCOS subjects, i.e. normal insulin binding, normal glucose transport activity and responsiveness, and impaired sensitivities for antilipolysis and glucose transport stimulation, are very similar to the conditions created in rat adipocytes by depletion of cellular adenosine (11, 12) . Addition of the nonmetabolized adenosine analog PIA to adenosine-depleted rat adipocytes normalizes insulin sensitivity, but has no impact on receptor binding or final transport responsiveness (12) . To determine whether cellular insulin insensitivity in PCOS might be related to the observation in rat adipocytes, cells from NC and PCOS subjects were incubated with insulin with or without PIA (2 mol/L) before transport assay. Treatment of NC or PCOS adipocytes with PIA had no influence on either basal or maximally insulin stimulated 3-OMG transport activities (not shown). Insulin sensitivity of NC cells was not influenced by PIA treatment (Fig. 1) . In contrast, there was a major effect on the shape of the doseresponse curve of PCOS cells, with a striking PIA-mediated leftward shift of the curve (Fig. 1) . This effect is more quantitatively depicted for each individual EC 50 value for five NC and seven PCOS subjects with control and PIA treatments (Fig. 2) . PIA did not influence insulin sensitivity in NC cells (EC 50 ϭ 112 Ϯ 18 vs. 108 Ϯ 20 pmol/L, before vs. after treatment). In all of the PCOS subjects, a major reduction in EC 50 values occurred, falling from 285 Ϯ 47 pmol/L before treatment to 70 Ϯ 15 with treatment (P Ͻ 0.005).
Discussion
Insulin resistance is now recognized as a common feature in women with PCOS (1-4, 21) . However, the mechanisms underlying this insulin-resistant state are poorly understood. Although insulin resistance is a nearly universal finding in obese PCOS subjects (2, 3), there is less unanimity about the presence of insulin resistance in nonobese PCOS subjects (3) (4) (5) 21) . To avoid the complications that might arise from comparing obese and nonobese populations, in the present study we have focused our investigation on NC and PCOS subjects matched for obesity. By controlling for obesity, differences in insulin action observed between the groups can be ascribed to PCOS. Under these conditions, we investigated possible sites of impaired insulin action in adipocytes from PCOS subjects.
There is evidence to suggest that the signaling events that lead to glucose transport stimulation and inhibition of lipolysis diverge at some point in the signaling cascade (22) . Adipocytes from the current PCOS subjects displayed normal maximal antilipolytic responsiveness to insulin. This is similar to the situation for glucose transport, where insulin responsiveness was also normal. Interestingly, in PCOS cells, the sensitivity to insulin's antilipolytic effects was significantly reduced. The 3-fold difference in EC 50 values for this response between NC and PCOS cells was the same as that for glucose transport stimulation. This suggests that the site of impaired insulin action in PCOS occurs before divergence of the glucose transport stimulation and antilipolytic pathways, and that the final effector systems responsible for antilipolysis are intact in PCOS.
Depletion of cellular adenosine in rat adipocytes creates a condition with normal insulin binding, normal glucose transport activity, and impaired insulin sensitivity for glucose transport stimulation (11, 12) that resembles the behavior in PCOS adipocytes. Similar observations have recently been made in human adipocytes (23) . Insulin sensitivity in adenosine-depleted rat adipocytes can be restored by treatment with a nonmetabolized adenosine analog, PIA (11, 12, 24) . We performed a similar manipulation in PCOS adipocytes and showed that PIA addition causes a leftward shift of the dose-response curve for glucose transport stimulation. As such, this effect leads to normalization of insulin sensitivity in these cells. In contrast, adenosine was without effect on the shape of the glucose transport dose-response curve in NC cells.
Studies in rat (24, 25) and human (23, 26) adipocytes have shown that insulin sensitivity for antilipolysis is also impaired by adenosine depletion. This would suggest that the adenosine-dependent event(s) in insulin signaling occur before the pathways for glucose transport and antilipolysis diverge, just as is the case for impaired insulin sensitivity in PCOS adipocytes. From these results it is reasonable to anticipate that PIA treatment of PCOS adipocytes would also normalize insulin sensitivity for antilipolysis. Unfortunately, due to the limited amount of tissue available from each biopsy we were unable to test this hypothesis directly.
Adenosine acts through a cell surface A 1 receptor to help maintain a normal state of insulin sensitivity for glucose transport (12, 27) . Although the specific steps in the insulin signal transduction cascade that are influenced by adenosine are unknown, the effect appears to involve the efficiency of the coupling mechanisms between the insulin receptor and the glucose transport system. The current results suggest that the mechanism of decreased insulin sensitivity in PCOS cells involves an adenosine-sensitive step, and this could involve alterations in adenosine production and release, expression of specific A 1 adenosine receptor subtypes, or the efficiency of A 1 receptors coupling through distinct G proteins to pathways that modulate insulin sensitivity. These possibilities are currently under investigation. Evidence in the current report argues against adenosine depletion or the presence of a generalized impairment of adenosine action as the cause of the insulin resistance. Endogenous adenosine maintains a tonic inhibition of adipocyte lipolysis (28 -30) . Removal of adenosine results in stimulation of basal lipolysis, often up to levels at which there is no further stimulation by lipolytic agents (23, 28, 30) . The normal basal and isoproterenol-stimulated rates of lipolysis in PCOS adipocytes indicate that the perturbation of adenosine signaling in PCOS may be specific for control of insulin sensitivity. There are several physiological conditions under which adenosine sensitivity of adipocytes is regulated. These include lactation (31) and chemically induced hypothyroidism (32) , where cells are more sensitive to adenosine. Massively obese humans display a reduced sensitivity to the antilipolytic effects of adenosine (33) that is improved after weight loss (30, 34) . As the subjects in the present study were matched for obesity, the later mechanism should not be responsible for the differences between NC and PCOS subjects. Rather, PCOS may represent yet another condition where adenosine signaling pathways are regulated.
The current results give rise to the question of whether the alterations in adenosine modulation of insulin sensitivity are selective for PCOS or occur in other insulin-resistant states. Studies in starved and streptozotocin-diabetic rats, both insulin-resistant conditions, showed no change in the ability of adenosine to regulate the insulin sensitivity of either glucose transport or antilipolysis (35) . Any alterations in insulin sensitivity in those conditions could be accounted for by changes in insulin binding. Impaired insulin sensitivity in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects was also found to be due to decreases in insulin binding (36) . The obese NC subjects studied in the current report could also be considered insulin resistant compared to lean individuals. Yet, their insulin sensitivity was not influenced by added PIA, suggesting that alterations in adenosine modulation of insulin action are not common to all insulin-resistant states. However, we are unaware of any systematic evaluation of this question, and further studies are necessary to establish whether this particular defect is indeed selective to PCOS.
The identity of the insulin signaling event(s) that is perturbed in PCOS is also an open question. Dunaif et al. have reported on increased serine phosphorylation of insulin receptors isolated from cultured fibroblasts in a subset of PCOS subjects (37) . Insulin-stimulated receptor tyrosine kinase activity was also decreased in these subjects. The potential importance of such a difference in receptor kinase activity in fibroblasts is uncertain, because these workers failed to find any correlations between receptor phosphorylation and either in vivo or in vitro insulin action (37) . Investigations of cultured fibroblasts obtained from many of the same subjects whose adipocytes were studied in the current report suggested that insulin action was, in fact, normal in fibroblasts (38) . In addition, our earlier studies indicated that insulin receptor kinase activity from PCOS adipocytes displayed little or no difference compared to NC adipocytes (8) . Considerable additional work will be necessary to identify the crucial steps. Signaling events downstream of the receptor kinase are currently being investigated as potential sites of the impaired insulin sensitivity of PCOS.
Evidence exists suggesting that PCOS can be an inherited disease (39) , and therefore, the form of insulin resistance present in these patients may also be genetic. It is possible that the adenosine-sensitive step in PCOS cells represents the site of a genetic abnormality in these patients, and further dissection of the insulin signaling pathways in PCOS may lead to important new insights into the pathogenesis of this common syndrome as well as better understanding of the basic mechanisms of insulin action.
